Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models-Reference-Cited by-同舟云学术

Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models

Published:2014-02 Issue: Volume:59 Page:66-75
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Alam Imranul,Gray Amie K.,Chu Kang,Ichikawa Shoji,Mohammad Khalid S.,Capannolo Marta,Capulli Mattia,Maurizi Antonio,Muraca Maurizio,Teti Anna,Econs Michael J.,Del Fattore Andrea

Funder

Telethon

European Calcified Tissue Society PhD studentship

Società Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro

National Institute of Health (NIH)

SYBIL - FP7-HEALTH-2013-INNOVATION

INTERBONE - FP7-PEOPLE-2011-IRSES

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference26 articles.

1. Osteopetrosis, a genetic and epidemiological study;Bollerslev;Clin Genet,1987

2. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment;Del Fattore;J Med Genet,2006

3. Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation;Waguespack;J Clin Endocrinol Metab,2007

4. Autosomal dominant osteopetrosis;Bollerslev;Clin Orthop Relat Res,1993

5. Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology;Van Wesenbeeck;Crit Rev Eukaryot Gene Expr,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background;Calcified Tissue International;2024-05-11

2. The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction;Calcified Tissue International;2024-03-14

3. Effect of Roflumilast, a Selective PDE4 Inhibitor, on Bone Phenotypes in ADO2 Mice;Calcified Tissue International;2024-02-01

4. Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humans;Molecular Therapy - Nucleic Acids;2023-09

5. The chloride antiporter CLCN7 is a modifier of lysosome dysfunction in FIG4 and VAC14 mutants;PLOS Genetics;2023-06-26